• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸2-(2-羟基-4-甲基苯基)氨基噻唑作为环氧化酶/脂氧合酶的双重抑制剂和自由基清除剂。首次通讯:体外研究。

2-(2-hydroxy-4-methylphenyl)aminothiazole hydrochloride as a dual inhibitor of cyclooxygenase/lipoxygenase and a free radical scavenger. 1st communication: in vitro studies.

作者信息

Bonne C, Muller A, Latour E, Tissie G, Emerit I, Modat G, Dornand J, Roch M, Giroud J P, Griswold D E

机构信息

Centre de Recherches, Laboratoire Chauvin, Montpellier, France.

出版信息

Arzneimittelforschung. 1989 Oct;39(10):1242-5.

PMID:2514692
Abstract

2-(2-Hydroxy-4-methylphenyl)aminothiazole hydrochloride (CBS-113 A) inhibits cyclooxygenase in platelets and 5-lipoxygenase in leukocytes at micromolar concentrations. On the other hand the drug is a potent scavenger of oxygen-derived free radicals. Moreover and possibly consequently, CBS-113 A inhibits the oxygen burst of stimulated leukocytes and the release of an interleukin 1-like compound from vascular endothelial cells in culture. These properties could lead to another activity of therapeutic interest in comparison with anti-inflammatory drugs already available.

摘要

2-(2-羟基-4-甲基苯基)氨基噻唑盐酸盐(CBS-113 A)在微摩尔浓度下可抑制血小板中的环氧化酶和白细胞中的5-脂氧合酶。另一方面,该药物是氧衍生自由基的有效清除剂。此外,可能因此,CBS-113 A可抑制受刺激白细胞的氧爆发以及培养的血管内皮细胞中白细胞介素1样化合物的释放。与现有的抗炎药物相比,这些特性可能会引发另一种具有治疗意义的活性。

相似文献

1
2-(2-hydroxy-4-methylphenyl)aminothiazole hydrochloride as a dual inhibitor of cyclooxygenase/lipoxygenase and a free radical scavenger. 1st communication: in vitro studies.盐酸2-(2-羟基-4-甲基苯基)氨基噻唑作为环氧化酶/脂氧合酶的双重抑制剂和自由基清除剂。首次通讯:体外研究。
Arzneimittelforschung. 1989 Oct;39(10):1242-5.
2
2-(2-hydroxy-4-methylphenyl)aminothiazole hydrochloride as a dual inhibitor of cyclooxygenase/lipoxygenase and a free radical scavenger. 2nd communication: anti-inflammatory activity.盐酸2-(2-羟基-4-甲基苯基)氨基噻唑作为环氧化酶/脂氧化酶的双重抑制剂和自由基清除剂。第二篇通讯:抗炎活性。
Arzneimittelforschung. 1989 Oct;39(10):1246-50.
3
Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.替泊沙林:一种花生四烯酸代谢的双重环氧化酶/5-脂氧合酶抑制剂,具有强大的抗炎活性和良好的胃肠道耐受性。
J Pharmacol Exp Ther. 1994 Dec;271(3):1399-408.
4
Anti-inflammatory activity of a dual inhibitor of cyclooxygenase and lipoxygenase pathways, CBS-1108 (2-acetylthiophene-2-thiazolylhydrazone).
Arzneimittelforschung. 1985;35(8):1260-3.
5
Vitamin E and the inhibition of platelet lipoxygenase.
Res Commun Chem Pathol Pharmacol. 1980 May;28(2):361-76.
6
Injury to rat hearts produced by an exogenous free radical generating system. Study into the role of arachidonic acid and eicosanoids.外源性自由基生成系统对大鼠心脏造成的损伤。花生四烯酸和类二十烷酸作用的研究。
J Pharmacol Exp Ther. 1987 Aug;242(2):673-85.
7
Dual inhibition of cyclooxygenase and lipoxygenase by 2-acetylthiophene 2-thiazolylhydrazone (CBS-1108) and effect on leukocyte migration in vivo.
Biochem Pharmacol. 1984 Jun 1;33(11):1757-62. doi: 10.1016/0006-2952(84)90346-0.
8
Action of cyclooxygenase (COX) and lipoxygenase (LOX) inhibitors as well as of oxygen free radical scavengers (OFRS) in the inflammation-induced vasodepression.环氧化酶(COX)和脂氧化酶(LOX)抑制剂以及氧自由基清除剂(OFRS)在炎症诱导的血管减压中的作用。
Biomed Biochim Acta. 1988;47(10-11):S320-3.
9
Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity.二苯并氧杂庚英酮羟胺和异羟肟酸:环氧合酶和5-脂氧合酶的双重抑制剂,具有强效局部抗炎活性。
J Med Chem. 1996 Jan 5;39(1):246-52. doi: 10.1021/jm950563z.
10
[Inhibition of arachidonic acid-induced ear edema in the mouse with lipoxygenase-, cyclo-oxygenase- and dual inhibitors].
Pharmazie. 1988 May;43(5):337-8.

引用本文的文献

1
LPS-stimulated bovine aortic endothelial cells produce IL-1 and IL-6 like activities.
Agents Actions. 1990 Jun;30(3-4):403-11. doi: 10.1007/BF01966305.